Your browser doesn't support javascript.
loading
Antimetastatic defense by CD8+ T cells.
Tallón de Lara, Paulino; Castañón, Héctor; Sterpi, Michelle; van den Broek, Maries.
Afiliação
  • Tallón de Lara P; Department of Medicine, Mount Sinai West and Mount Sinai Morningside, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: paulino.tallondelara@mssm.edu.
  • Castañón H; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, Zurich, Switzerland.
  • Sterpi M; Department of Medicine, Mount Sinai West and Mount Sinai Morningside, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • van den Broek M; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, Zurich, Switzerland.
Trends Cancer ; 8(2): 145-157, 2022 02.
Article em En | MEDLINE | ID: mdl-34815204
ABSTRACT
Metastasis is an intricate process whereby tumor cells migrate from the primary tumor, survive in the circulation, seed distal organs, and proliferate to create metastatic foci. CD8+ T cells can detect and eliminate tumor cells. Research on CD8+ T cell-dependent antitumor immunity has classically focused on its role in the primary tumor. There is increasing evidence, however, that CD8+ T cells have unique antimetastatic functions in various steps of the metastatic cascade. Here, we review the mechanisms whereby CD8+ T cells control metastatic lesions. We discuss their role in each step of metastasis, metastatic dormancy, and metastatic clonal evolution as well as the consequent clinical repercussions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article